Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB382437

CLEC9a Antibody (8F9), Alexa Fluor™ 350, Novus Biologicals™
SDP

Catalog No. NB382437 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB382437 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB382437 Supplier Novus Biologicals Supplier No. NBP308246AF350
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

CLEC9a Monoclonal antibody specifically detects CLEC9a in Human samples. It is validated for Flow Cytometry, ELISA, Immunocytochemistry/ Immunofluorescence

Specifications

Antigen CLEC9a
Applications Flow Cytometry, ELISA, Immunofluorescence
Classification Monoclonal
Clone 8F9
Conjugate Alexa Fluor 350
Formulation 50mM Sodium Borate
Gene Alias C-type lectin domain family 9 member A, C-type lectin domain family 9, member A, DNGR1, HEEE9341, UNQ9341
Host Species Mouse
Immunogen RBL-2H3 cells expressing human CLEC9a fused to an HA epitope
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Immunology, Stem Cells
Primary or Secondary Primary
Gene ID (Entrez) 283420
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.